In a filing, Atyr Pharma Inc revealed its Director SCHIMMEL PAUL acquired Company’s shares for reported $0.1 million on Jul 24 ’24. In the deal valued at $1.93 per share,52,300 shares were bought. As a result of this transaction, SCHIMMEL PAUL now holds 413,023 shares worth roughly $0.72 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SCHIMMEL PAUL bought 6,648 shares, generating $12,075 in total proceeds. Upon buying the shares at $1.82, the Director now owns 360,723 shares.
Before that, SCHIMMEL PAUL bought 41,052 shares. Atyr Pharma Inc shares valued at $71,500 were divested by the Director at a price of $1.74 per share. As a result of the transaction, SCHIMMEL PAUL now holds 354,075 shares, worth roughly $0.62 million.
Oppenheimer downgraded its Atyr Pharma Inc [ATYR] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in mid October with a ‘”an Outperform”‘ rating. Piper Sandler began covering ATYR with “an Overweight” recommendation on September 21, 2021. Laidlaw started covering the stock on May 10, 2021. It rated ATYR as “a Buy”.
Price Performance Review of ATYR
On Tuesday, Atyr Pharma Inc [NASDAQ:ATYR] saw its stock fall -3.87% to $1.74. Over the last five days, the stock has lost -6.95%. Atyr Pharma Inc shares have risen nearly 23.40% since the year began. Nevertheless, the stocks have fallen -13.00% over the past one year. While a 52-week high of $2.50 was reached on 07/25/24, a 52-week low of $1.08 was recorded on 01/02/24. SMA at 50 days reached $1.7713, while 200 days put it at $1.6374.
Levels Of Support And Resistance For ATYR Stock
The 24-hour chart illustrates a support level at 1.6667, which if violated will result in even more drops to 1.5933. On the upside, there is a resistance level at 1.8667. A further resistance level may holdings at 1.9933. The Relative Strength Index (RSI) on the 14-day chart is 44.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.1436, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.68%. Stochastics%K at 13.41% indicates the stock is a buying.
How much short interest is there in Atyr Pharma Inc?
A steep rise in short interest was recorded in Atyr Pharma Inc stocks on
